Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial-Reference-Cited by-同舟云学术

Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial

Published:2015-04-10 Issue:7 Volume:65 Page:1126-1131
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Baert Filip,Kondragunta Venkateswarlu,Lockton Steven,Vande Casteele Niels^ORCID,Hauenstein Scott,Singh Sharat,Karmiris Konstantinos,Ferrante Marc,Gils Ann,Vermeire Séverine

Publisher

BMJ

Subject

Gastroenterology

Reference24 articles.

1. Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease;Karmiris;Gastroenterology,2009

2. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review;Gisbert;Am J Gastroenterol,2009

3. Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review;Billioud;Am J Gastroenterol,2011

4. Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients;Baert;J Crohns Colitis,2013

5. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays;Frontiers in Immunology;2024-08-22

2. A prediction method for the individual serum concentration and therapeutic effect for optimizing adalimumab therapy in inflammatory bowel disease;Journal of Pharmacy and Pharmacology;2024-07-15

3. What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022;Frontiers in Pharmacology;2024-07-08

4. High Adalimumab Dose at Beginning Maintenance Therapy in Crohn’s disease Patients;2023-11-29

5. Therapeutic Antibodies in Medicine;Molecules;2023-09-05